Extramural Funding

Print

The following is a list of active extramural funding opportunities, provided as a courtesy to UCLA Jonsson Comprehensive Cancer Center members. To be included on this list, funding must be unlimited or not administered directly by the JCCC.

Listings are generally updated as a batch on a monthly basis. Entries are ordered by posting date, with most recent postings first. Funding opportunities are removed from this list once their final application due date has passed.

**IMPORTANT** The 21st Century Cures Act was signed into law in December 2016, and authorizes $1.8 billion over seven years to fund the Beau Biden Cancer Moonshot Initiative. The National Cancer Institute has released numerous funding opportunity announcements, and additional funding initiatives are anticipated. You are encouraged to visit their website for a complete and current list of funding opportunities that may be available to you.

Posted June 8, 2018

2018 Lori Monroe Scholarships in Translational Lung Cancer Research

Application Due Date(s): Wednesday, August 1

How to Apply: Applications are due via the IASLCF’s online portal.

Description: The objective of this award is to support research that improves the care of individuals with lung cancers and to reduce the burden of these diseases. Examples include studies: (1) designed to define the molecular bases of lung cancer risk assessment; (2) to improve molecular diagnostic studies designed to detect the lung cancer early and guide curative-intent therapy; (3) predictive features guiding the use of targeted or immune oncology therapy to reduce recurrence after standard curative-intent strategies in early stage disease; (4) or to improve the outcomes or cure patients with metastatic lung cancer. Studies designed to facilitate care by minimizing treatment side effects or illuminating the causes of nonsmoking related lung cancer are encouraged, as well.

The maximum funding for the award will be in the amount of $200,000. The award amount will be $100,000 per year for up to two years. The second year of support is based on demonstrating satisfactory progress as determined by LCFA/IASLCF as well as the availability of funding from LCFA/IASLCF. No more than 25 percent of the requested budget may be used for an awardee’s salary and/or fringe benefits and no award budget may be used to fund the purchase of permanent equipment. No indirect costs are provided. Any unused award funds at the conclusion of the study period will be returned to the study sponsor.


Histiocytic Disorders Research Grant

Application Due Date(s): July 1, annual

How to Apply: Applications are due via the Histiocytic Association's online portal

Description: The foundation will award grants of up to $50,000 for studies into the causes, mechanisms, and improved means of treatment for histiocytic disorders. While all areas of research relevant to the histiocytoses will be considered, priority will be given to studies related to mechanisms of disease pathogenesis; biology (maturation, migration, and immune function) of dendritic cells, macrophages, and/or lymphocytes in disease pathogenesis; derangements of cytokine production or function; CNS pathology; neuropsychiatric consequences; studies of rare forms (juvenile xanthogranuloma, Erdheim-Chester disease, Rosai-Dorfman disease); studies of histiocytic disorders in adults; and discovery of new disease markers.

Posted May 23, 2018

2018 Pew-Stewart Scholars Program for Cancer Research

Application Due Date(s): Friday, June 15

How to Apply: Please submit one to two paragraphs on your proposal and biosketch to Nancy Presseau via email.

Description: Award is $300,000, distributed over four years. Applicants must be conducting highly innovative cancer research. Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor or instructor are not eligible. The JCCC can only nominate a single candidate.


Gabrielle's Angels Foundation 2018 Conventional and Integrative Grants

Application Due Date(s): Friday, June 15

How to Apply: Please submit one page research proposal, CV, and letter of nomination from your Division Chair (including the date of your appointment) to Nancy Presseau via email.

Description: Gabrielle’s Angel Foundation for Cancer Research is soliciting grant applications to fund innovative and insightful medical research. Gabrielle’s Angel has focused on supporting promising junior investigators conducting scientific research that can be applied to improving the treatment of patients with these diseases. Gabrielle’s Angel has invited the JCCC to nominate only one application per category/per institution for their Conventional and Integrative grants.

Conventional Grants are conventional or mainstream projects, and Integrative Grants fund integrative research projects that explore evidence-based complementary interventions such as acupuncture, nutrition, meditation, yoga, etc. Also supports clinical trials and/or pre-clinical research that addresses reducing patients’ physical and emotional distress during or after cancer therapy.

The award for each grant is $75,000 a year for three years. Overhead/indirect costs may not exceed 10 percent of the total grant award.

Posted May 6, 2018

Defense Health Program Concept Award

Application Due Date(s): Letter of Intent due July 26, 2018.

How to Apply: For more information, visit their website.

Description: Supports new ideas in the early stages of development representing innovative, high-risk/high-gain research. Emphasis on innovation and impact. New Investigators: Supports applicants early in their faculty appointments or in the process of developing independent research careers. Clinical trials not allowed. Preliminary data required, but may be from outside of lung cancer. Military relevance strongly encouraged. Maximum funding of $350,000 in direct costs (plus indirect costs). Period of performance should not exceed two years.


Defense Health Program Idea Development Award

Application Due Date(s): Preproposal due June 26, 2018.

How to Apply: For more information, visit their website.

Description: Supports new ideas in the early stages of development representing innovative, high-risk/high-gain research. Emphasis on innovation and impact. Supports applicants early in their faculty appointments or in the process of developing independent research careers. Clinical trials not allowed. Preliminary data required, but may be from outside of lung cancer. Military relevance strongly encouraged.

Maximum funding of $350,000 in direct costs (plus indirect costs). Period of performance should not exceed two years.


Defense Health Program Investigator-Initiated Translational Research Award

Application Due Date(s): Preproposal due June 26, 2018.

How to Apply: For more information, visit their website.

Description: Independent investigators at or above the level of Assistant Professor (or equivalent). Supports translational research that will develop promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Intended to fund a broad range of translational studies. Clinical trials not allowed. Preliminary Date required, but may be from outside of lung cancer. Military relevance strongly encouraged.

Maximum funding of $400,000 in direct costs (plus indirect costs). Period of performance should not exceed two years.


Defense Health Program Translational Research Partnership Award

Application Due Date(s): Preproposal due June 26, 2018.

How to Apply: For more information, visit their website.

Description: Investigators at or above the level of Assistant Professor (or equivalent). Supports partnerships between clinicians and laboratory scientists that accelerate ideas in lung cancer into clinical applications. One partner is strongly encouraged to be from a Department of Defense military treatment facility or laboratory, or Veterans Affairs medical center or research laboratory. Non-Traditional Partnerships are encouraged. Clinical trials are allowed. Preliminary data required, but may be from outside of lung cancer.

Maximum combined funding of $900,000 in direct costs (plus indirect costs). Maximum period of performance is three years. Military relevance strongly encouraged.


Defense Health Program Career Development Award

Application Due Date(s): Letter of Intent due August 28, 2018

How to Apply: For more information, visit their website

Description: Supports independent, early-career investigators to conduct impactful research with the mentorship of an experienced cancer researcher. Must address at least one of the FY18 PRCRP Topic Areas, and at least one of the FY18 PRCRP Military Relevance Focus Areas. Preliminary data are not required, and clinical trials are not allowed.

Maximum funding for the entire period of performance is $360,000 in direct costs (plus indirect costs). Maximum period of performance is three years


Defense Health Program Idea Award with Special Focus

Application Due Date(s): Preproposal due June 20, 2018

How to Apply: For more information, visit their website

Description: Supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in cancer research relevant to Service members, veterans, other military beneficiaries, and the American Public. Emphasis on innovation and military relevance/impact. Must address at least one of the FY18 PRCRP Topic Areas, and at least one of the FY18 PRCRP Military Relevance Focus Areas. Inclusion of preliminary data discouraged, and clinical trials are not allowed.

Maximum funding for the entire period of performance is $400,000 in direct costs (plus indirect costs) Maximum period of performance is two years


Defense Health Program Translational Team Science Award

Application Due Date(s): Preproposal due June 20, 2018

How to Apply: For more information, visit their website

Description: At least two and up to three PIs must partner in one overarching correlative or translational research study in at least one of the required FY18 PRCRP Topic Areas. The PIs must be at or above the level of Assistant Professor or equivalent. At least one military/Department of Veterans Affairs investigator is encouraged to be included as an equal partner.

Supports hypothesis-driven translational studies associated with an ongoing or completed clinical trial and are focused on research for the next-phase clinical research. Must address at least one of the FY18 PRCRP Topic Areas, and at least one of the FY18 PRCRP Military Relevance Focus Areas. Encourages research in quality of life, longitudinal cancer risk studies, and risk straficiation for primary and metastatic disease. Preliminary data are required, and clinical trials are allowed.

Maximum funding for the entire period of performance is $1,000,000 in direct costs (plus indirect costs). Maximum period of performance is four years


Defense Health Program Impact Award

Application Due Date(s): Preproposal due June 20, 2018

How to Apply: For more information, visit their website

Description: Supports hypothesis-driven high-impact research. Encourages application that support the ideas that specifically focus on critical scientific and clinical cancer issued. Emphasis on impact, transformation, and continuity of research. Must address at least one of the FY18 PRCRP Topic Areas, and at least one of the FY18 PRCRP Military Relevance Focus Areas. Preliminary data are required, and clinical trials are allowed.

Maximum funding for the entire period of performance is $1,000,000 in direct costs (plus indirect costs). Maximum period of performance is three years.

Posted April 11, 2018

Damon Runyon Cancer Research Foundation Runyon-Rachleff Innovation Award

Application Due Date(s): July 6, 2018

How to Apply: For more information, visit their website

Description: The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances.

The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.Awards are made to institutions for support of the Damon Runyon-Rachleff Innovation Investigators. All awards are approved by the Board of Directors of the Damon Runyon Cancer Research Foundation acting upon the recommendation of the Innovation Award Committee.


Leukemia and Lymphoma Society Career Development Grant

Application Due Date(s): October 2, 2018

How to Apply: For more information, visit their website

Description: Scholar Award: $110,000 per year for five years / Scholar in Clinical Research Award: $125,000 per year for five years / Special Fellow Award: $67,000 per year for two or three years / Fellow Award: $60,000 per year for three years.


Cancer Research Institute Clinic & Laboratory Integration Program (CLIP)

Application Due Date(s): November 1, 2018

How to Apply: For more information, visit their website

Description: The development of new and effective cancer treatment requires the translation of basic laboratory discoveries into novel therapies that can be tested in patients. This area of translational research—where laboratory findings move into clinical testing and where questions from clinical studies are brought back into the lab—is critical to bringing new and better immunotherapies to patients.

The Cancer Research Institute established CLIP to support investigators who are studying critical topics at the intersection of laboratory and clinical research. CLIP grants provide up to $200,000 over a two-year period.


Damon Runyon Cancer Research Foundation Physician-Scientist Training Award

Application Due Date(s): December 3, 2018

How to Apply: For more information, visit their website

Description: Physician-scientists who are both clinically trained and expert researchers are essential to the successful translation of scientific discovery into more effective patient therapies. They have the unique capacity to blend their insights from treating patients and working in the laboratory in a way that enables and accelerates medical advances. However, the pipeline of physician-scientists is dwindling. The decline in this vital cadre of cancer researchers is occurring at a time when cancer research holds the greatest promise of improving survival and quality of life among cancer patients. A growing shortage of physician-scientists means that major laboratory research discoveries will progress to patient application ever more slowly. If the shortage continues unabated, some may not reach patient application at all, thus presenting a crisis in cancer research.

Posted March 20, 2018

Margaret E. Early Medical Research Trust 2019 Cancer Research Grants

Application Due Date(s): Internal committee review consideration is June 11, 2018 by 5:00 p.m. PST.

How to Apply: Interested faculty must send a single PDF file including a cover page (which includes name, campus address w. mail code, email address, phone number, title of research proposal), a one-page brief description of their research proposal, and a NIH biosketch.  Renewal applicants must include in addition to the same PDF file a progress report (no more than one page) describing their research accomplishment funded by the Early Trust. Please send complete PDF via email to REncarnacion@mednet.ucla.edu.

Description: UCLA may submit up to eight applications (inclusive of new and renewals). The Margaret E. Early Medical Research Trust is currently seeking applications on research in the causes, treatment and potential cures of cancer and related disease. Awards are funded for one year (Jan. 1, 2019 to Dec. 31, 2019) with a possible renewal of one to two additional years upon satisfactory progress. The award amount is for $75,000 ($62,000 direct cost and $12,500 indirect cost). Funds may be used for salaries, supplies, equipment, animals and housing for animals.

Current UCLA awardees must submit renewal grant application to receive a second or third year of funding. The renewal applications will be counted as part of the eight allowed for UCLA to submit.